APO Research
Talk to an analyst

APO RESEARCH · REPORT

Contraceptive Drug Eluting Devices

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Contraceptive Drug Eluting Devices Market Outlook and Growth Opportunities 2026

28 December 2025201 pages

Choose your research edition.

Industry ResearchContraceptive Drug Eluting Devices Industry Research Report 2026139 pages · $2,950 USDIndustry Growth & TrendsGlobal Contraceptive Drug Eluting Devices Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal Contraceptive Drug Eluting Devices Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Contraceptive Drug Eluting Devices Market Outlook and Growth Opportunities 2026201 pages · $4,250 USDMarket Analysis & ForecastGlobal Contraceptive Drug Eluting Devices Market Analysis and Forecast 2026-2032203 pages · $4,950 USD

Market perspective

The global Contraceptive Drug Eluting Devices market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Contraceptive Drug Eluting Devices is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Contraceptive Drug Eluting Devices is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Contraceptive Drug Eluting Devices is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Contraceptive Drug Eluting Devices market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Contraceptive Drug Eluting Devices market include CooperSurgical, Egemen International, ERENLER MEDIKAL, Gyneas, Laboratoire CCD, Medical Engineering Corporation, Melbea, Meril Life Sciences and Mona Lisa, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Contraceptive Drug Eluting Devices market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Contraceptive Drug Eluting Devices and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Contraceptive Drug Eluting Devices sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Contraceptive Drug Eluting Devices market size, projected growth trends, production technologies, key applications, and end-use industries.

Contraceptive Drug Eluting Devices Segment by Company

CooperSurgical

Egemen International

ERENLER MEDIKAL

Gyneas

Laboratoire CCD

Medical Engineering Corporation

Melbea

Meril Life Sciences

Mona Lisa

Pregna

Pregna International

Prosan International

Rongbo Medical

SMB Corporation of India

AbbVie

Bayer

Contraceptive Drug Eluting Devices Segment by Type

Non-biodegradable

Biodegradable

Contraceptive Drug Eluting Devices Segment by Application

Subcutaneously

Uterus

Contraceptive Drug Eluting Devices Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Contraceptive Drug Eluting Devices status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Contraceptive Drug Eluting Devices market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Contraceptive Drug Eluting Devices significant trends, drivers, influence factors in global and regions.

6. To analyze Contraceptive Drug Eluting Devices competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Contraceptive Drug Eluting Devices market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Contraceptive Drug Eluting Devices and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Contraceptive Drug Eluting Devices.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Contraceptive Drug Eluting Devices market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Contraceptive Drug Eluting Devices industry.

Chapter 3: Detailed analysis of Contraceptive Drug Eluting Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Contraceptive Drug Eluting Devices in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Contraceptive Drug Eluting Devices in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Contraceptive Drug Eluting Devices Industry Trends Table 2. Contraceptive Drug Eluting Devices Industry Drivers Table 3. Contraceptive Drug Eluting Devices Industry Opportunities and Challenges Table 4. Contraceptive Drug Eluting Devices Industry Restraints Table 5. Global Contraceptive Drug Eluting Devices Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Contraceptive Drug Eluting Devices Revenue Share by Company (2021-2026) Table 7. Global Contraceptive Drug Eluting Devices Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Contraceptive Drug Eluting Devices Sales Volume Share by Company (2021-2026) Table 9. Global Contraceptive Drug Eluting Devices Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Contraceptive Drug Eluting Devices Company Ranking, (2024-2026) & (USD Million) Table 11. Global Contraceptive Drug Eluting Devices Key Company Manufacturing Base & Headquarters Table 12. Global Contraceptive Drug Eluting Devices Company, Product Type & Application Table 13. Global Contraceptive Drug Eluting Devices Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Contraceptive Drug Eluting Devices by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Non-biodegradable Table 18. Significant Companies of Biodegradable Table 19. Global Contraceptive Drug Eluting Devices Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Contraceptive Drug Eluting Devices Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Contraceptive Drug Eluting Devices Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Contraceptive Drug Eluting Devices Sales Volume Share by Type (2021-2026) Table 23. Global Contraceptive Drug Eluting Devices Sales Volume Share by Type (2027-2032) Table 24. Global Contraceptive Drug Eluting Devices Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Contraceptive Drug Eluting Devices Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Contraceptive Drug Eluting Devices Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Contraceptive Drug Eluting Devices Sales Value Share by Type (2021-2026) Table 28. Global Contraceptive Drug Eluting Devices Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Subcutaneously Table 30. Significant Companies of Uterus Table 31. Global Contraceptive Drug Eluting Devices Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Contraceptive Drug Eluting Devices Sales Volume by Application (2021-2026) & (K Units) Table 33. Global Contraceptive Drug Eluting Devices Sales Volume by Application (2027-2032) & (K Units) Table 34. Global Contraceptive Drug Eluting Devices Sales Volume Share by Application (2021-2026) Table 35. Global Contraceptive Drug Eluting Devices Sales Volume Share by Application (2027-2032) Table 36. Global Contraceptive Drug Eluting Devices Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Contraceptive Drug Eluting Devices Sales Value by Application (2021-2026) & (US$ Million) Table 38. Global Contraceptive Drug Eluting Devices Sales Value by Application (2027-2032) & (US$ Million) Table 39. Global Contraceptive Drug Eluting Devices Sales Value Share by Application (2021-2026) Table 40. Global Contraceptive Drug Eluting Devices Sales Value Share by Application (2027-2032) Table 41. Global Contraceptive Drug Eluting Devices Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Contraceptive Drug Eluting Devices Sales by Region (2021-2026) & (K Units) Table 43. Global Contraceptive Drug Eluting Devices Sales Market Share by Region (2021-2026) Table 44. Global Contraceptive Drug Eluting Devices Sales by Region (2027-2032) & (K Units) Table 45. Global Contraceptive Drug Eluting Devices Sales Market Share by Region (2027-2032) Table 46. Global Contraceptive Drug Eluting Devices Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Contraceptive Drug Eluting Devices Sales Value by Region (2021-2026) & (US$ Million) Table 48. Global Contraceptive Drug Eluting Devices Sales Value Share by Region (2021-2026) Table 49. Global Contraceptive Drug Eluting Devices Sales Value by Region (2027-2032) & (US$ Million) Table 50. Global Contraceptive Drug Eluting Devices Sales Value Share by Region (2027-2032) Table 51. Global Contraceptive Drug Eluting Devices Market Average Price (US$/Unit) by Region (2021-2026) Table 52. Global Contraceptive Drug Eluting Devices Market Average Price (US$/Unit) by Region (2027-2032) Table 53. Global Contraceptive Drug Eluting Devices Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 54. Global Contraceptive Drug Eluting Devices Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 55. Global Contraceptive Drug Eluting Devices Sales by Country (2021-2026) & (K Units) Table 56. Global Contraceptive Drug Eluting Devices Sales Market Share by Country (2021-2026) Table 57. Global Contraceptive Drug Eluting Devices Sales by Country (2027-2032) & (K Units) Table 58. Global Contraceptive Drug Eluting Devices Sales Market Share by Country (2027-2032) Table 59. Global Contraceptive Drug Eluting Devices Sales Value by Country (2021-2026) & (US$ Million) Table 60. Global Contraceptive Drug Eluting Devices Sales Value Market Share by Country (2021-2026) Table 61. Global Contraceptive Drug Eluting Devices Sales Value by Country (2027-2032) & (US$ Million) Table 62. Global Contraceptive Drug Eluting Devices Sales Value Market Share by Country (2027-2032) Table 63. CooperSurgical Company Information Table 64. CooperSurgical Business Overview Table 65. CooperSurgical Contraceptive Drug Eluting Devices Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. CooperSurgical Contraceptive Drug Eluting Devices Product Portfolio Table 67. CooperSurgical Recent Development Table 68. Egemen International Company Information Table 69. Egemen International Business Overview Table 70. Egemen International Contraceptive Drug Eluting Devices Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Egemen International Contraceptive Drug Eluting Devices Product Portfolio Table 72. Egemen International Recent Development Table 73. ERENLER MEDIKAL Company Information Table 74. ERENLER MEDIKAL Business Overview Table 75. ERENLER MEDIKAL Contraceptive Drug Eluting Devices Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. ERENLER MEDIKAL Contraceptive Drug Eluting Devices Product Portfolio Table 77. ERENLER MEDIKAL Recent Development Table 78. Gyneas Company Information Table 79. Gyneas Business Overview Table 80. Gyneas Contraceptive Drug Eluting Devices Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Gyneas Contraceptive Drug Eluting Devices Product Portfolio Table 82. Gyneas Recent Development Table 83. Laboratoire CCD Company Information Table 84. Laboratoire CCD Business Overview Table 85. Laboratoire CCD Contraceptive Drug Eluting Devices Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Laboratoire CCD Contraceptive Drug Eluting Devices Product Portfolio Table 87. Laboratoire CCD Recent Development Table 88. Medical Engineering Corporation Company Information Table 89. Medical Engineering Corporation Business Overview Table 90. Medical Engineering Corporation Contraceptive Drug Eluting Devices Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Medical Engineering Corporation Contraceptive Drug Eluting Devices Product Portfolio Table 92. Medical Engineering Corporation Recent Development Table 93. Melbea Company Information Table 94. Melbea Business Overview Table 95. Melbea Contraceptive Drug Eluting Devices Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Melbea Contraceptive Drug Eluting Devices Product Portfolio Table 97. Melbea Recent Development Table 98. Meril Life Sciences Company Information Table 99. Meril Life Sciences Business Overview Table 100. Meril Life Sciences Contraceptive Drug Eluting Devices Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Meril Life Sciences Contraceptive Drug Eluting Devices Product Portfolio Table 102. Meril Life Sciences Recent Development Table 103. Mona Lisa Company Information Table 104. Mona Lisa Business Overview Table 105. Mona Lisa Contraceptive Drug Eluting Devices Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Mona Lisa Contraceptive Drug Eluting Devices Product Portfolio Table 107. Mona Lisa Recent Development Table 108. Pregna Company Information Table 109. Pregna Business Overview Table 110. Pregna Contraceptive Drug Eluting Devices Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Pregna Contraceptive Drug Eluting Devices Product Portfolio Table 112. Pregna Recent Development Table 113. Pregna International Company Information Table 114. Pregna International Business Overview Table 115. Pregna International Contraceptive Drug Eluting Devices Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. Pregna International Contraceptive Drug Eluting Devices Product Portfolio Table 117. Pregna International Recent Development Table 118. Prosan International Company Information Table 119. Prosan International Business Overview Table 120. Prosan International Contraceptive Drug Eluting Devices Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 121. Prosan International Contraceptive Drug Eluting Devices Product Portfolio Table 122. Prosan International Recent Development Table 123. Rongbo Medical Company Information Table 124. Rongbo Medical Business Overview Table 125. Rongbo Medical Contraceptive Drug Eluting Devices Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 126. Rongbo Medical Contraceptive Drug Eluting Devices Product Portfolio Table 127. Rongbo Medical Recent Development Table 128. SMB Corporation of India Company Information Table 129. SMB Corporation of India Business Overview Table 130. SMB Corporation of India Contraceptive Drug Eluting Devices Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 131. SMB Corporation of India Contraceptive Drug Eluting Devices Product Portfolio Table 132. SMB Corporation of India Recent Development Table 133. AbbVie Company Information Table 134. AbbVie Business Overview Table 135. AbbVie Contraceptive Drug Eluting Devices Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 136. AbbVie Contraceptive Drug Eluting Devices Product Portfolio Table 137. AbbVie Recent Development Table 138. Bayer Company Information Table 139. Bayer Business Overview Table 140. Bayer Contraceptive Drug Eluting Devices Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 141. Bayer Contraceptive Drug Eluting Devices Product Portfolio Table 142. Bayer Recent Development Table 143. Key Raw Materials Table 144. Raw Materials Key Suppliers Table 145. Contraceptive Drug Eluting Devices Distributors List Table 146. Contraceptive Drug Eluting Devices Customers List Table 147. Research Programs/Design for This Report Table 148. Authors List of This Report Table 149. Secondary Sources Table 150. Primary Sources List of Figures Figure 1. Contraceptive Drug Eluting Devices Product Image Figure 2. Global Contraceptive Drug Eluting Devices Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Contraceptive Drug Eluting Devices Sales Value (2021-2032) & (US$ Million) Figure 4. Global Contraceptive Drug Eluting Devices Sales (2021-2032) & (K Units) Figure 5. Global Contraceptive Drug Eluting Devices Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Contraceptive Drug Eluting Devices Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Non-biodegradable Image Figure 10. Biodegradable Image Figure 11. Global Contraceptive Drug Eluting Devices Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Contraceptive Drug Eluting Devices Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Contraceptive Drug Eluting Devices Sales Volume Share by Type (2021-2032) Figure 14. Global Contraceptive Drug Eluting Devices Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Contraceptive Drug Eluting Devices Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Contraceptive Drug Eluting Devices Sales Value Share by Type (2021-2032) Figure 17. Subcutaneously Image Figure 18. Uterus Image Figure 19. Global Contraceptive Drug Eluting Devices Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Contraceptive Drug Eluting Devices Sales Volume Share 2021 VS 2025 VS 2032 Figure 21. Global Contraceptive Drug Eluting Devices Sales Volume Share by Application (2021-2032) Figure 22. Global Contraceptive Drug Eluting Devices Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Contraceptive Drug Eluting Devices Sales Value Share 2021 VS 2025 VS 2032 Figure 24. Global Contraceptive Drug Eluting Devices Sales Value Share by Application (2021-2032) Figure 25. Global Contraceptive Drug Eluting Devices Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 26. Global Contraceptive Drug Eluting Devices Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 27. Global Contraceptive Drug Eluting Devices Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 28. Global Contraceptive Drug Eluting Devices Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 29. North America Contraceptive Drug Eluting Devices Sales Value (2021-2032) & (US$ Million) Figure 30. North America Contraceptive Drug Eluting Devices Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Europe Contraceptive Drug Eluting Devices Sales Value (2021-2032) & (US$ Million) Figure 32. Europe Contraceptive Drug Eluting Devices Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Asia-Pacific Contraceptive Drug Eluting Devices Sales Value (2021-2032) & (US$ Million) Figure 34. Asia-Pacific Contraceptive Drug Eluting Devices Sales Value Share by Country (%), 2025 VS 2032 Figure 35. South America Contraceptive Drug Eluting Devices Sales Value (2021-2032) & (US$ Million) Figure 36. South America Contraceptive Drug Eluting Devices Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Middle East & Africa Contraceptive Drug Eluting Devices Sales Value (2021-2032) & (US$ Million) Figure 38. Middle East & Africa Contraceptive Drug Eluting Devices Sales Value Share by Country (%), 2025 VS 2032 Figure 39. USA Contraceptive Drug Eluting Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. USA Contraceptive Drug Eluting Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. USA Contraceptive Drug Eluting Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Canada Contraceptive Drug Eluting Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Canada Contraceptive Drug Eluting Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Canada Contraceptive Drug Eluting Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Mexico Contraceptive Drug Eluting Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Mexico Contraceptive Drug Eluting Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Mexico Contraceptive Drug Eluting Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Germany Contraceptive Drug Eluting Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Germany Contraceptive Drug Eluting Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Germany Contraceptive Drug Eluting Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. France Contraceptive Drug Eluting Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. France Contraceptive Drug Eluting Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. France Contraceptive Drug Eluting Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. U.K. Contraceptive Drug Eluting Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. U.K. Contraceptive Drug Eluting Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. U.K. Contraceptive Drug Eluting Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Italy Contraceptive Drug Eluting Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Italy Contraceptive Drug Eluting Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Italy Contraceptive Drug Eluting Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Spain Contraceptive Drug Eluting Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Spain Contraceptive Drug Eluting Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Spain Contraceptive Drug Eluting Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Russia Contraceptive Drug Eluting Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Russia Contraceptive Drug Eluting Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Russia Contraceptive Drug Eluting Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Netherlands Contraceptive Drug Eluting Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Netherlands Contraceptive Drug Eluting Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Netherlands Contraceptive Drug Eluting Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Nordic Countries Contraceptive Drug Eluting Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Nordic Countries Contraceptive Drug Eluting Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Nordic Countries Contraceptive Drug Eluting Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. China Contraceptive Drug Eluting Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. China Contraceptive Drug Eluting Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. China Contraceptive Drug Eluting Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Japan Contraceptive Drug Eluting Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Japan Contraceptive Drug Eluting Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Japan Contraceptive Drug Eluting Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. South Korea Contraceptive Drug Eluting Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. South Korea Contraceptive Drug Eluting Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. South Korea Contraceptive Drug Eluting Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. India Contraceptive Drug Eluting Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. India Contraceptive Drug Eluting Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. India Contraceptive Drug Eluting Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Australia Contraceptive Drug Eluting Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Australia Contraceptive Drug Eluting Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Australia Contraceptive Drug Eluting Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Southeast Asia Contraceptive Drug Eluting Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Southeast Asia Contraceptive Drug Eluting Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Southeast Asia Contraceptive Drug Eluting Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Brazil Contraceptive Drug Eluting Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Brazil Contraceptive Drug Eluting Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Brazil Contraceptive Drug Eluting Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Argentina Contraceptive Drug Eluting Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Argentina Contraceptive Drug Eluting Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Argentina Contraceptive Drug Eluting Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Chile Contraceptive Drug Eluting Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Chile Contraceptive Drug Eluting Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Chile Contraceptive Drug Eluting Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Colombia Contraceptive Drug Eluting Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Colombia Contraceptive Drug Eluting Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Colombia Contraceptive Drug Eluting Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Peru Contraceptive Drug Eluting Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Peru Contraceptive Drug Eluting Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Peru Contraceptive Drug Eluting Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Saudi Arabia Contraceptive Drug Eluting Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Saudi Arabia Contraceptive Drug Eluting Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Contraceptive Drug Eluting Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Israel Contraceptive Drug Eluting Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Israel Arabia Contraceptive Drug Eluting Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Israel Arabia Contraceptive Drug Eluting Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. UAE Contraceptive Drug Eluting Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. UAE Contraceptive Drug Eluting Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. UAE Contraceptive Drug Eluting Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Turkey Contraceptive Drug Eluting Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Turkey Contraceptive Drug Eluting Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Turkey Contraceptive Drug Eluting Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Iran Contraceptive Drug Eluting Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Iran Contraceptive Drug Eluting Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Iran Contraceptive Drug Eluting Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Egypt Contraceptive Drug Eluting Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Egypt Contraceptive Drug Eluting Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Egypt Contraceptive Drug Eluting Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Contraceptive Drug Eluting Devices Value Chain Figure 124. Manufacturing Cost Structure Figure 125. Contraceptive Drug Eluting Devices Sales Mode & Process Figure 126. Direct Comparison with Distribution Share Figure 127. Distributors Profiles Figure 128. Years Considered Figure 129. Research Process Figure 130. Key Executives Interviewed

Scope & coverage.

Types
  • Non-biodegradable
  • Biodegradable
Applications
  • Subcutaneously
  • Uterus
Companies covered
  • CooperSurgical
  • Egemen International
  • ERENLER MEDIKAL
  • Gyneas
  • Laboratoire CCD
  • Medical Engineering Corporation
  • Melbea
  • Meril Life Sciences
  • Mona Lisa
  • Pregna
  • Pregna International
  • Prosan International
  • Rongbo Medical
  • SMB Corporation of India
  • AbbVie
  • Bayer

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Contraceptive Drug Eluting Devices Sales Value (2021-2032)
  4. 1.2.2 Global Contraceptive Drug Eluting Devices Sales Volume (2021-2032)
  5. 1.2.3 Global Contraceptive Drug Eluting Devices Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Contraceptive Drug Eluting Devices Market Dynamics
  1. 2.1 Contraceptive Drug Eluting Devices Industry Trends
  2. 2.2 Contraceptive Drug Eluting Devices Industry Drivers
  3. 2.3 Contraceptive Drug Eluting Devices Industry Opportunities and Challenges
  4. 2.4 Contraceptive Drug Eluting Devices Industry Restraints
3 Contraceptive Drug Eluting Devices Market by Company
  1. 3.1 Global Contraceptive Drug Eluting Devices Company Revenue Ranking in 2025
  2. 3.2 Global Contraceptive Drug Eluting Devices Revenue by Company (2021-2026)
  3. 3.3 Global Contraceptive Drug Eluting Devices Sales Volume by Company (2021-2026)
  4. 3.4 Global Contraceptive Drug Eluting Devices Average Price by Company (2021-2026)
  5. 3.5 Global Contraceptive Drug Eluting Devices Company Ranking (2024-2026)
  6. 3.6 Global Contraceptive Drug Eluting Devices Company Manufacturing Base and Headquarters
  7. 3.7 Global Contraceptive Drug Eluting Devices Company Product Type and Application
  8. 3.8 Global Contraceptive Drug Eluting Devices Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Contraceptive Drug Eluting Devices Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Contraceptive Drug Eluting Devices Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Contraceptive Drug Eluting Devices Market by Type
  1. 4.1 Contraceptive Drug Eluting Devices Type Introduction
  2. 4.1.1 Non-biodegradable
  3. 4.1.2 Biodegradable
  4. 4.2 Global Contraceptive Drug Eluting Devices Sales Volume by Type
  5. 4.2.1 Global Contraceptive Drug Eluting Devices Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Contraceptive Drug Eluting Devices Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Contraceptive Drug Eluting Devices Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Contraceptive Drug Eluting Devices Sales Value by Type
  9. 4.3.1 Global Contraceptive Drug Eluting Devices Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Contraceptive Drug Eluting Devices Sales Value by Type (2021-2032)
  11. 4.3.3 Global Contraceptive Drug Eluting Devices Sales Value Share by Type (2021-2032)
5 Contraceptive Drug Eluting Devices Market by Application
  1. 5.1 Contraceptive Drug Eluting Devices Application Introduction
  2. 5.1.1 Subcutaneously
  3. 5.1.2 Uterus
  4. 5.2 Global Contraceptive Drug Eluting Devices Sales Volume by Application
  5. 5.2.1 Global Contraceptive Drug Eluting Devices Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Contraceptive Drug Eluting Devices Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Contraceptive Drug Eluting Devices Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Contraceptive Drug Eluting Devices Sales Value by Application
  9. 5.3.1 Global Contraceptive Drug Eluting Devices Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Contraceptive Drug Eluting Devices Sales Value by Application (2021-2032)
  11. 5.3.3 Global Contraceptive Drug Eluting Devices Sales Value Share by Application (2021-2032)
6 Contraceptive Drug Eluting Devices Regional Sales and Value Analysis
  1. 6.1 Global Contraceptive Drug Eluting Devices Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Contraceptive Drug Eluting Devices Sales by Region (2021-2032)
  3. 6.2.1 Global Contraceptive Drug Eluting Devices Sales by Region: 2021-2026
  4. 6.2.2 Global Contraceptive Drug Eluting Devices Sales by Region (2027-2032)
  5. 6.3 Global Contraceptive Drug Eluting Devices Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Contraceptive Drug Eluting Devices Sales Value by Region (2021-2032)
  7. 6.4.1 Global Contraceptive Drug Eluting Devices Sales Value by Region: 2021-2026
  8. 6.4.2 Global Contraceptive Drug Eluting Devices Sales Value by Region (2027-2032)
  9. 6.5 Global Contraceptive Drug Eluting Devices Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Contraceptive Drug Eluting Devices Sales Value (2021-2032)
  12. 6.6.2 North America Contraceptive Drug Eluting Devices Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Contraceptive Drug Eluting Devices Sales Value (2021-2032)
  15. 6.7.2 Europe Contraceptive Drug Eluting Devices Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Contraceptive Drug Eluting Devices Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Contraceptive Drug Eluting Devices Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Contraceptive Drug Eluting Devices Sales Value (2021-2032)
  21. 6.9.2 South America Contraceptive Drug Eluting Devices Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Contraceptive Drug Eluting Devices Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Contraceptive Drug Eluting Devices Sales Value Share by Country, 2025 VS 2032
7 Contraceptive Drug Eluting Devices Country-level Sales and Value Analysis
  1. 7.1 Global Contraceptive Drug Eluting Devices Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Contraceptive Drug Eluting Devices Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Contraceptive Drug Eluting Devices Sales by Country (2021-2032)
  4. 7.3.1 Global Contraceptive Drug Eluting Devices Sales by Country (2021-2026)
  5. 7.3.2 Global Contraceptive Drug Eluting Devices Sales by Country (2027-2032)
  6. 7.4 Global Contraceptive Drug Eluting Devices Sales Value by Country (2021-2032)
  7. 7.4.1 Global Contraceptive Drug Eluting Devices Sales Value by Country (2021-2026)
  8. 7.4.2 Global Contraceptive Drug Eluting Devices Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Contraceptive Drug Eluting Devices Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Contraceptive Drug Eluting Devices Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Contraceptive Drug Eluting Devices Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Contraceptive Drug Eluting Devices Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Contraceptive Drug Eluting Devices Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Contraceptive Drug Eluting Devices Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Contraceptive Drug Eluting Devices Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Contraceptive Drug Eluting Devices Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Contraceptive Drug Eluting Devices Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Contraceptive Drug Eluting Devices Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Contraceptive Drug Eluting Devices Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Contraceptive Drug Eluting Devices Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Contraceptive Drug Eluting Devices Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Contraceptive Drug Eluting Devices Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Contraceptive Drug Eluting Devices Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Contraceptive Drug Eluting Devices Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Contraceptive Drug Eluting Devices Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Contraceptive Drug Eluting Devices Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Contraceptive Drug Eluting Devices Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Contraceptive Drug Eluting Devices Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Contraceptive Drug Eluting Devices Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Contraceptive Drug Eluting Devices Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Contraceptive Drug Eluting Devices Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Contraceptive Drug Eluting Devices Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Contraceptive Drug Eluting Devices Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Contraceptive Drug Eluting Devices Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Contraceptive Drug Eluting Devices Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Contraceptive Drug Eluting Devices Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Contraceptive Drug Eluting Devices Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Contraceptive Drug Eluting Devices Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Contraceptive Drug Eluting Devices Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Contraceptive Drug Eluting Devices Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Contraceptive Drug Eluting Devices Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Contraceptive Drug Eluting Devices Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Contraceptive Drug Eluting Devices Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Contraceptive Drug Eluting Devices Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Contraceptive Drug Eluting Devices Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Contraceptive Drug Eluting Devices Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Contraceptive Drug Eluting Devices Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Contraceptive Drug Eluting Devices Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Contraceptive Drug Eluting Devices Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Contraceptive Drug Eluting Devices Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Contraceptive Drug Eluting Devices Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Contraceptive Drug Eluting Devices Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Contraceptive Drug Eluting Devices Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Contraceptive Drug Eluting Devices Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Contraceptive Drug Eluting Devices Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Contraceptive Drug Eluting Devices Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Contraceptive Drug Eluting Devices Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Contraceptive Drug Eluting Devices Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Contraceptive Drug Eluting Devices Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Contraceptive Drug Eluting Devices Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Contraceptive Drug Eluting Devices Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Contraceptive Drug Eluting Devices Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Contraceptive Drug Eluting Devices Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Contraceptive Drug Eluting Devices Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Contraceptive Drug Eluting Devices Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Contraceptive Drug Eluting Devices Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Contraceptive Drug Eluting Devices Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Contraceptive Drug Eluting Devices Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Contraceptive Drug Eluting Devices Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Contraceptive Drug Eluting Devices Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Contraceptive Drug Eluting Devices Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Contraceptive Drug Eluting Devices Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Contraceptive Drug Eluting Devices Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Contraceptive Drug Eluting Devices Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Contraceptive Drug Eluting Devices Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Contraceptive Drug Eluting Devices Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Contraceptive Drug Eluting Devices Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Contraceptive Drug Eluting Devices Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Contraceptive Drug Eluting Devices Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Contraceptive Drug Eluting Devices Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Contraceptive Drug Eluting Devices Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Contraceptive Drug Eluting Devices Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Contraceptive Drug Eluting Devices Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Contraceptive Drug Eluting Devices Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Contraceptive Drug Eluting Devices Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Contraceptive Drug Eluting Devices Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Contraceptive Drug Eluting Devices Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Contraceptive Drug Eluting Devices Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Contraceptive Drug Eluting Devices Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Contraceptive Drug Eluting Devices Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Contraceptive Drug Eluting Devices Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Contraceptive Drug Eluting Devices Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 CooperSurgical
  2. 8.1.1 CooperSurgical Company Information
  3. 8.1.2 CooperSurgical Business Overview
  4. 8.1.3 CooperSurgical Contraceptive Drug Eluting Devices Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 CooperSurgical Contraceptive Drug Eluting Devices Product Portfolio
  6. 8.1.5 CooperSurgical Recent Developments
  7. 8.2 Egemen International
  8. 8.2.1 Egemen International Company Information
  9. 8.2.2 Egemen International Business Overview
  10. 8.2.3 Egemen International Contraceptive Drug Eluting Devices Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Egemen International Contraceptive Drug Eluting Devices Product Portfolio
  12. 8.2.5 Egemen International Recent Developments
  13. 8.3 ERENLER MEDIKAL
  14. 8.3.1 ERENLER MEDIKAL Company Information
  15. 8.3.2 ERENLER MEDIKAL Business Overview
  16. 8.3.3 ERENLER MEDIKAL Contraceptive Drug Eluting Devices Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 ERENLER MEDIKAL Contraceptive Drug Eluting Devices Product Portfolio
  18. 8.3.5 ERENLER MEDIKAL Recent Developments
  19. 8.4 Gyneas
  20. 8.4.1 Gyneas Company Information
  21. 8.4.2 Gyneas Business Overview
  22. 8.4.3 Gyneas Contraceptive Drug Eluting Devices Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Gyneas Contraceptive Drug Eluting Devices Product Portfolio
  24. 8.4.5 Gyneas Recent Developments
  25. 8.5 Laboratoire CCD
  26. 8.5.1 Laboratoire CCD Company Information
  27. 8.5.2 Laboratoire CCD Business Overview
  28. 8.5.3 Laboratoire CCD Contraceptive Drug Eluting Devices Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Laboratoire CCD Contraceptive Drug Eluting Devices Product Portfolio
  30. 8.5.5 Laboratoire CCD Recent Developments
  31. 8.6 Medical Engineering Corporation
  32. 8.6.1 Medical Engineering Corporation Company Information
  33. 8.6.2 Medical Engineering Corporation Business Overview
  34. 8.6.3 Medical Engineering Corporation Contraceptive Drug Eluting Devices Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Medical Engineering Corporation Contraceptive Drug Eluting Devices Product Portfolio
  36. 8.6.5 Medical Engineering Corporation Recent Developments
  37. 8.7 Melbea
  38. 8.7.1 Melbea Company Information
  39. 8.7.2 Melbea Business Overview
  40. 8.7.3 Melbea Contraceptive Drug Eluting Devices Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Melbea Contraceptive Drug Eluting Devices Product Portfolio
  42. 8.7.5 Melbea Recent Developments
  43. 8.8 Meril Life Sciences
  44. 8.8.1 Meril Life Sciences Company Information
  45. 8.8.2 Meril Life Sciences Business Overview
  46. 8.8.3 Meril Life Sciences Contraceptive Drug Eluting Devices Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Meril Life Sciences Contraceptive Drug Eluting Devices Product Portfolio
  48. 8.8.5 Meril Life Sciences Recent Developments
  49. 8.9 Mona Lisa
  50. 8.9.1 Mona Lisa Company Information
  51. 8.9.2 Mona Lisa Business Overview
  52. 8.9.3 Mona Lisa Contraceptive Drug Eluting Devices Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Mona Lisa Contraceptive Drug Eluting Devices Product Portfolio
  54. 8.9.5 Mona Lisa Recent Developments
  55. 8.10 Pregna
  56. 8.10.1 Pregna Company Information
  57. 8.10.2 Pregna Business Overview
  58. 8.10.3 Pregna Contraceptive Drug Eluting Devices Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Pregna Contraceptive Drug Eluting Devices Product Portfolio
  60. 8.10.5 Pregna Recent Developments
  61. 8.11 Pregna International
  62. 8.11.1 Pregna International Company Information
  63. 8.11.2 Pregna International Business Overview
  64. 8.11.3 Pregna International Contraceptive Drug Eluting Devices Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Pregna International Contraceptive Drug Eluting Devices Product Portfolio
  66. 8.11.5 Pregna International Recent Developments
  67. 8.12 Prosan International
  68. 8.12.1 Prosan International Company Information
  69. 8.12.2 Prosan International Business Overview
  70. 8.12.3 Prosan International Contraceptive Drug Eluting Devices Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Prosan International Contraceptive Drug Eluting Devices Product Portfolio
  72. 8.12.5 Prosan International Recent Developments
  73. 8.13 Rongbo Medical
  74. 8.13.1 Rongbo Medical Company Information
  75. 8.13.2 Rongbo Medical Business Overview
  76. 8.13.3 Rongbo Medical Contraceptive Drug Eluting Devices Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Rongbo Medical Contraceptive Drug Eluting Devices Product Portfolio
  78. 8.13.5 Rongbo Medical Recent Developments
  79. 8.14 SMB Corporation of India
  80. 8.14.1 SMB Corporation of India Company Information
  81. 8.14.2 SMB Corporation of India Business Overview
  82. 8.14.3 SMB Corporation of India Contraceptive Drug Eluting Devices Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 SMB Corporation of India Contraceptive Drug Eluting Devices Product Portfolio
  84. 8.14.5 SMB Corporation of India Recent Developments
  85. 8.15 AbbVie
  86. 8.15.1 AbbVie Company Information
  87. 8.15.2 AbbVie Business Overview
  88. 8.15.3 AbbVie Contraceptive Drug Eluting Devices Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 AbbVie Contraceptive Drug Eluting Devices Product Portfolio
  90. 8.15.5 AbbVie Recent Developments
  91. 8.16 Bayer
  92. 8.16.1 Bayer Company Information
  93. 8.16.2 Bayer Business Overview
  94. 8.16.3 Bayer Contraceptive Drug Eluting Devices Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 Bayer Contraceptive Drug Eluting Devices Product Portfolio
  96. 8.16.5 Bayer Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Contraceptive Drug Eluting Devices Value Chain Analysis
  2. 9.1.1 Contraceptive Drug Eluting Devices Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Contraceptive Drug Eluting Devices Sales Mode & Process
  6. 9.2 Contraceptive Drug Eluting Devices Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Contraceptive Drug Eluting Devices Distributors
  9. 9.2.3 Contraceptive Drug Eluting Devices Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst